Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Inflammation

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions

Inflammation

Interventions

DRUG

Dapagliflozin (DAPA)

Participants will receive 10mg of Dapagliflozin per day for three days.

Trial Locations (1)

RECRUITING

Washington University, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER